Company Overview
| Stock Name | 德萊建業集團有限公司 |
|---|---|
| Stock Code | 08122 |
| Company Full Name | 德萊建業集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | To be extracted |
| Listing Date | 2015-10-09 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | To be extracted |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供配售 + 發售現有證券 |
| Listing Board | GEM |
| Website | -- |
| Share Registrar | |
| Registrar Contact | To be extracted |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.33 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 65,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 260,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Use of Proceeds
| Use of Proceeds | 1、約55%或84.8百萬港元用于擴大生產設施； 2、約35%或53.9百萬港元，用于擴大產品系列； 3、約10%或15.4百萬港元用于擴大重要新興市場（金磚四國）及重要國際市場（歐洲及美國）的銷售、市場推廣及分銷業務。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Piper Jaffray Asia Limited CE AEG682
Joint Bookrunners (1)
PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154
Joint Lead Managers (1)
PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | To be extracted |
|---|---|
| Company Secretary | To be extracted |
No director data available.
Major Shareholders
No major shareholder data available.
